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Abstract 
In recent years the trend in health care has been toward 
developing devices that supports faster diagnosis and 
therapeutic turnaround time. These needs have 
facilitated rapid growth in research and development of 
point-of-care diagnostic testing (POCT). Heart disease 
is a major cause of death all over the world. According 
to “Center for Disease Control and Prevention”, heart 
attack is the leading cause of death in US. Every year 
an estimated 785,000 Americans had a new coronary 
attack and about 470,000 had a recurrent attack [1].  C-
reactive protein (CRP) is an inflammatory cardiovascular 
biomarker which is over-expressed in a person 
susceptible of a heart disease [2] and thus rapid 
detection of CRP from patient serum samples may be 
clinically relevant in diagnosing  cardiac events such as 
acute myocardial infarction. The novel properties of 
nanoscale materials  such as the enhanced surface 
area and size based confinement of  biomolecules, have 
the potential to increase the sensitivity of the diagnostics 
platforms in order to detect the protein biomarkers such 
as CRP at very low concentrations and give early 
indication of heart condition [2].  
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Introduction 
The methodology for developing a protein biosensor has 
been presented and it focuses on the use of carbon 
nanotubes and polymer nanofibers based nano 
composites that have been electrospun in the form of 
“nanowebs”. These nanowebs have been surface 
modified to function as sensors for detecting C-reactive 
protein(CRP). Detection sensitivity of CRP was 
achieved in the femtogram/mL regime   from phosphate 
buffered saline solutions and in human serum.  The 
designed biosensor is three orders more sensitive than 
ELISA. Sensitivity enhancement was achieved by tuning 
the   charge transduction at the solid /liquid interface on 
the nanoweb matrix. 
The nanoimprinting of fibers on the PCB was achieved 
using electrospinning method. 15kV of potential 
difference was applied at 10 cm distance maintaining 
1.5ml/hr flow rate. The nanoweb biosensor chips 
comprise of a base printed circuit platform. The platform 
is overlaid with the nanoporous nanoweb layer, which is 
then encapsulated by microfluidic manifolds 
manufactured using polydimethylsiloxane for fluid 
encapsulation and confinement . We have used CRP 
protein in phosphate buffered saline buffer as well as 
50% human serum for evaluating the sensor 
performance. Printed circuit board (PCB) chips 
comprising of gold comb shaped designs of dimensions 
10 mm x 10 mm in length, finger width of 1 mm with 
spacing of 1 mm, as shown in Figure 2A, were 
manufactured with a FR4 passivation layer.  
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Figure 2. A) Optical image of the protein biosensor patterned 
with nanowebs on PCB. B) SEM image of PVA+CNT nanoweb 
with an average diameter 200nm. 
Results and Discussion 
Two sets of dose response experiments were performed 
to test the capabilities of the nanoweb sensor platform. 
The first set was focused on detecting human serum-
CRP (hs-CRP) when aliquoted in isotonic buffer solution, 
0.15 M phosphate buffer saline (PBS). Zero dose 
corresponding to 0.15 M PBS was injected into the 
manifold and the measured impedance was considered 
as the baseline measurement. All the impedance 
measurements for different dose concentrations of CRP 
were normalized to this baseline measurement. Starting 
from the lowest dose within the range, 150 μL of CRP 
spiked buffer was injected into the manifold, incubated 
for 15 minutes and impedance measurement was taken. 
The change in impedance from baseline measurement 
was calculated and converted into percentage change of 
impedance from baseline readings.  
Figure 4. Graphical representation of C-reactive protein dose 
response in phosphate buffered saline (red bars) and human 
serum (blue bars) as compared to standard ELISA test (black 
points) 
The sensor performed as a switch, with a significant 
change in impedance at the 1 fg/mL dose and 
impedance comparable to the baseline signals for lower 
doses. The percentage change in the impedance over 
the concentration range from 1 fg/mL to 100 ng/mL has 
been represented. The changes to the impedance have 
been expressed as a percentage change from the 
antibody saturation.  The limit of detection (LoD) in both 
the PBS and in the hs cases were 1 fg/mL. The 
regression trends in both the cases sustained at high 
values of 0.75 and 0.76, respectively.  
The gray line with both dots is an overlay of the CRP 
protein tested using the gold-standard method, ELISA 
[8]. Data was plotted in comparison to the Nanomonitor 
dose range. There is a clear distinction in both the 
sensitivity and linear dynamic range of detection. The 
sensitivity with the Nanomonitor was in the femto-gram 
regime where as the ELISA has low picogram-per-mL 
detectability. Additionally, ELISA is a lab-bench based 
analysis versus Nanomonitor is a hand-held device 
methodology. 
The CNT embedded ultrafine fibers helps to bind the 
target proteins in the sensor and hence sensor device 
achieves amplification of the measured electrochemical 
impedance signal associated with protein binding.  The 
changes to the impedance were comparable in both the 
ionic buffer as well as in the human serum. The protein 
binding is significantly enhanced at the low 
concentrations which in turn improves the sensitivity. 
However, future work will be focused on the testing 
different protein types and biomolecule sensing at 
femtogram/ml concentration. 
Clean the metal surfaces with 10 mL of isopropyl 
alcohol (IPA) and air dry the samples for 10 minutes. 
Nanowebs constituted of 10 mg of CNT in 100ml of 10 
% PVA were electrospun.  The dimensions of the 
nanowebs used for the experiments were 13.2 mm x 
13.2 mm. The nanoweb is encapsulated with a 
polydimethylsiloxane (PDMS) manifold with dimension 
13 mm x 13 mm.  The manifold has a groove of 5 mm 
depth to enable the localization of the nanoweb onto 
the sensor surface.  
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The PVA sample have characteristic C-H peaks at 
670cm-1 and  2910cm-1 [3], but the 670cm-1 peak is 
absent in PVA –CNT sample.  The peak at 924cm-1 is 
O-H  out of plane motion of the carboxylic group. At 
1329cm-1 observes the CH2 stretch peaks present in 
both samples. The –OH stretch peak is at 3290cm-1 
and 1650 [4,5], C-C stretch is a 1420 cm-1[6] and the 
C-OH stretch peaks are at 840cm-1, 1090 cm-1 and 
1320 cm-1. A –COOH stretch peak is observed at 1710 
cm-1 [7] was observed in composite sample but not in 
pure PVA samples. This difference may indicate an 
interaction between PVA and CNT matrix. 
Figure 3. FTIR for PVA, PVA_CNT samples  
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EIS measurements were taken using the Gamry 
Reference 600 potentiostat (Figure 4A) with a fixed 
voltage of 10 mV. A range of frequencies were swept 
across the working and the reference terminals and the 
impedance was measured at each of the frequency 
points. Impedance values at the 100 Hz frequency was 
extracted using Microsoft Excel spreadsheet macros and 
were plottted as the change in impedance at that 
experimental step The percentage change in impedance 
for PBS varied from 38% to 60% and for human serum it 
varied from 45% to 70% over the dose range.  
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